Rheumatoid arthritis (RA), one of the most common of the chronic inflammatory autoimmune
diseases (CIADs), is recognized as an independent cardiovascular risk factor. Traditional …

Insufficient recommendations do not support the clinical use of carotid ultrasonography for
further risk stratification in moderate-to-high risk patients with cardiovascular disease (CVD) …

Background Several cardiovascular (CV) risk algorithms are available to predict CV events
in the general population. However, their performance in patients with rheumatoid arthritis …

Objective Because carotid plaques predict the development of cardiovascular events in RA,
we aimed to assess if the combined use of the systematic coronary risk evaluation (SCORE) …

Objective: To evaluate the rate of subclinical carotid atherosclerosis and clinical significance
of immunoinflammatory markers in patients with rheumatoid arthritis (RA) at low …

Abstract Interleukin (IL) 1, and its family member, IL-1 receptor antagonist (IL-1ra), are
involved in the pathogenesis and inflammation perpetuation of patients with rheumatoid …

Introduction Rheumatoid arthritis (RA) exhibit a cardiovascular (CV) risk that is 1.5–2.0 times
higher compared to the general population. This CV risk excess is likely caused by the …

Background Modulators of triglyceride metabolism include lipoprotein lipase (LPL),
angiopoietin-like protein 4 (ANGPTL4), and apolipoprotein C-3 (ApoC3). There is evidence …

Cardiovascular diseases, including ischemic heart disease and stroke, reportedly comprise
the top two causes of global mortality [1]. Eighty percent of cardiovascular events are …

The monocytes to high-density lipoprotein (HDL)-cholesterol ratio (MHR) indicates
inflammation based on the anti-inflammatory properties of HDL-cholesterol as well as the …